ATEC
Alphatecs
–
Index: NASDAQ; Sector: Healthcare; Industry: Medical Equipment & Supplies;
Marketcap: 439.19M; Volume: 88.61K; AvgVol 3m: 358.99K; Beta: 1.44;
Cost estimate:
P/E: –; EPS: -1.12; EPS growth quarter/prev quarter: 6.30%;
EPS growth this year: 9.00%; EPS growth past 5 years: ;
EPS ttm: -1.12;
P/S: 3.50; P/B: 22.50; P/Cashflow: 13.61; P/FCF: ;
Sales: 121.29M; Sales growth quarter/prev quarter: 8.40%; Sales growth past 5 years: -6.00%;
Profitability:
Gross Margin: 69.30%; Profit Margin: -56.20%; Operating Margin: -46.70%;
ROA – return on assets: -41.10%; ROE – return on equity: -184.70%; LT Debt/Equity: 3.52; Total Debt/Equity: 3.54;
Dividend: –; Dividend Yield (%): –;
Insider Ownership: 16.90%; Insider Transactions:-0.49%;
Institutional Ownership: 46.80%; Institutional Transactions: 2.48%;
Data update: 07.10.2020.